U.K. Imaging Services Market Share Analysis Report, 2023-2032
The U.K. imaging services market size was exhibited at USD 14.7 billion in 2022 and is projected to hit around USD 26.59 billion by 2032, growing at a CAGR of 6.11% during the forecast period 2023 to 2032.
Key Pointers:
U.K. Imaging Services Market Report Scope
|
Report Coverage |
Details |
|
Market Size in 2023 |
USD 15.59 Billion |
|
Market Size by 2032 |
USD 26.59 Billion |
|
Growth Rate from 2023 to 2032 |
CAGR of 6.11% |
|
Base year |
2022 |
|
Forecast period |
2023 to 2032 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments covered |
Modality, end-use |
|
Key companies profiled |
Alliance Medical; InHealth Group; Neuromed Diagnostic Imaging Center; UNILAB; Medica Group; TIC Health; The Clinic; Affidea Group; Vista Health; Medical Imaging Partnership, Rutherford Diagnostics |
Medical imaging technologies are highly useful in detecting changes in the appearance of organs, tissues, and arteries, as well as diagnosing various diseases like cancer. Each modality has its own set of advantages for effectively identifying a variety of medical conditions. The prevalence of various disorders is predicted to increase market growth.
Emerging innovations in medical imaging technology and their adoption by service providers are expanding the market size. For instance, in May 2021, Alliance Medical and Expandable Healthcare announced the launch of Mobile Medical Plus in the U.K., a mobile imaging unit with an in-patient facility. Furthermore, the market is likely to grow over the forecast period due to the increased prevalence of chronic diseases such as cancer and cardiovascular disorders, which necessitates the use of advanced medical imaging technologies for diagnosis. As per the International Agency for Research on Cancer, about 457,960 new cancer cases were diagnosed in the U.K. in 2021, with 179,648 fatalities in the same year.
With the adoption of modern imaging technology, the number of imaging service providers in the U.K. is rapidly increasing. According to the Organization for Economic Co-operation and Development (OECD), hospitals had around 7.8 MRI units and 9 CT units installed per 1,000,000 population in 2020. Furthermore, the rising frequency of CT scans in the U.K. is predicted to boost the overall market growth. According to the same source, CT scans were performed in U.K. hospitals at a rate of 103 per 1,000 people in 2019. The low cost of CT scans compared to MRI scans is also expected to increase their uptake.
In order to grow their services and presence, the market's leading competitors are undertaking various efforts such as acquisitions and funding of medium and small-sized organizations. For instance, in March 2022, Fortius Clinic, U.K.'s single largest orthopedic group with an international reputation in orthopedics and MSK, was acquired by Affidea Group, the leading European provider of diagnostic imaging, outpatient, and cancer care services. In July 2021, Rutherford Health entered into a partnership with Somerset NHS Foundation Trust, to provide diagnostic services through a new diagnostics facility in Somerset, England. The diagnostics facility is expected to offer a variety of diagnostic services and assist in the delivery of test results.
Modality Insights
MRI held the largest revenue share of about 34.9% in 2022. This service provides better soft tissue contrast than other imaging services and can be useful in diagnosing a wide variety of diseases and conditions and therefore help in effective surgical treatment planning. Advances in technology are further expected to increase the demand for these services. In January 2022, In a partnership with Siemens Healthineers, InHealth Group launched an application of syngo Virtual Cockpit technology at Frimley Park Hospital. This will assist in remote scanning as well as the rapid transfer of specialized knowledge between MRI scanners, resulting in enhanced access to clinical experts, increased efficiency, and a better patient experience.
CT scan is expected to witness considerable growth during the forecast period. The main benefit of this imaging modality is that it allows for detailed imaging of bone, blood vessels, and soft tissues. Additionally, this service is available at affordable costs and consumes less time in comparison to other modalities. Several population-level screening programs are being implemented as part of an increased emphasis on cancer prevention and early detection; and CT is used primarily as part of the lung health check program.
End-use Insights
The hospital segment held the largest share of nearly 49.8% in 2022 owing to the adoption of advanced imaging modalities. For instance, in September 2021, Hexham General Hospital installed the Inhealth MRI scanner with a partnership between Northumbria Healthcare NHS Foundation Trust. Since the installation, over 300 patients visited for important diagnostic scans each month. Furthermore, the increasing prevalence of various medical conditions, such as cancer and cardiac disorders is also expected to boost the segment growth. As per the International Agency for Research on Cancer, in 2020, around 457,960 new cancer cases were diagnosed in the U.K., and the cases are expected to reach 1,514,420 by 2032.
The diagnostic imaging centers segment is expected to expand at a lucrative rate during the forecast period, owing to increasing partnerships and acquisitions between diagnostic imaging centers and other healthcare organizations. For instance, in March 2021, Fortius Clinic, the U.K.'s single largest orthopedic group, was acquired by Affidea Group, the leading European provider of diagnostic imaging, outpatient, and cancer care services. Furthermore, the availability of several imaging modalities in a single facility, as well as reimbursement policies for imaging procedures, are projected to have a positive impact on the end-use segment.
Some of the prominent players in the U.K. Imaging Services Market include:
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the U.K. Imaging Services market.
By Modality
By End-use
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Modality
1.1.2. End-use
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Nova one advisor internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Modality outlook
2.2.2. End-use outlook
2.3. Competitive Insights
Chapter 3. U.K. Imaging Services Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of chronic s
3.4.1.2. Technological advancements
3.4.1.3. Growing awareness of medical imaging
3.4.2. Market restraint analysis
3.4.2.1. High radiation exposure
3.4.2.2. Lack of technically sound staff
3.5. U.K. Imaging Services Market Analysis Tools
3.5.1. Industry Analysis - Porter’s Five Forces
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. U.K. Imaging Services Market: Modality Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. X-rays
4.1.2. CT scans
4.1.3. MRI scans
4.1.4. Ultrasound
4.1.5. Nuclear Medicine scans
4.2. Modality Market Share, 2018 & 2032
4.3. Segment Dashboard
4.4. U.K. Imaging Services Market by Modality Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2032 for the following
4.5.1. X-rays
4.5.1.1. X-rays market estimates and forecast 2018 to 2032
4.5.2. CT scans
4.5.2.1. CT scans market estimates and forecast 2018 to 2032
4.5.3. MRI scans
4.5.3.1. MRI scans market estimates and forecast 2018 to 2032
4.5.4. Ultrasound
4.5.4.1. Ultrasound market estimates and forecast 2018 to 2032
4.5.5. Nuclear medicine scans
4.5.5.1. Nuclear medicine scans market estimates and forecast 2018 to 2032
Chapter 5. U.K. Imaging Services Market: End-use Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Hospitals
5.1.2. Diagnostic imaging centers
5.1.3. Others
5.2. End-use Market Share, 2018 & 2032
5.3. Segment Dashboard
5.4. U.K. Imaging Services Market by End-use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2032 for the following
5.5.1. Hospitals
5.5.1.1. Hospitals estimates and forecast 2018 to 2032
5.5.2. Diagnostic Imaging Centers
5.5.2.1. Imaging centers market estimates and forecast 2018 to 2032
5.5.3. Others
5.5.3.1. Others market estimates and forecast 2018 to 2032
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.2.1. Innovators
6.3. Vendor Landscape
6.3.1. List of key distributors and channel partners
6.3.2. Key customers
6.3.3. Key company market share analysis, 2020
6.3.4. Alliance Medical
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. InHealth Group
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. Neuromed Diagnostic Imaging Center
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. UNILAB
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. Medica Group
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. TIC Health
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. The radiology clinic
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives
6.3.11. Affidea Group
6.3.11.1. Company overview
6.3.11.2. Financial performance
6.3.11.3. Product benchmarking
6.3.11.4. Strategic initiatives
6.3.12. Vista Health
6.3.12.1. Company overview
6.3.12.2. Financial performance
6.3.12.3. Product benchmarking
6.3.12.4. Strategic initiatives
6.3.13. Medical Imaging Partnership
6.3.13.1. Company overview
6.3.13.2. Financial performance
6.3.13.3. Product benchmarking
6.3.13.4. Strategic initiatives
6.3.14. Rutherford Diagnostics
6.3.14.1. Company overview
6.3.14.2. Financial performance
6.3.14.3. Product benchmarking
6.3.14.4. Strategic initiatives
6.3.15. Medical Imaging Partnership
6.3.15.1. Company overview
6.3.15.2. Financial performance
6.3.15.3. Product benchmarking
6.3.15.4. Strategic initiatives
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers